Jüri Teras

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Johannes Breedt, Jüri Teras, Jānis Gardovskis et al. · Antimicrobial Agents and Chemotherapy · 2005 · 191 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

William O’Riordan, Alison J. McManus, Jüri Teras et al. · Clinical Infectious Diseases · 2018 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

Krasimir Vasilev, Galina Reshedko, Remus Orăsan et al. · Journal of Antimicrobial Chemotherapy · 2008 · 101 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +16

Tetratrichomonads from the oral cavity and respiratory tract of humans

Kateřina Kutišová, J. Kulda, Ivan Čepička et al. · Parasitology · 2005 · 65 citations

Life Sciences, Infectious Diseases, Microbiology +9

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

Kristy K. Broman, Tasha M. Hughes, Lesly A. Dossett et al. · Cancer · 2021 · 62 citations · Full text

Medicine, Oncology, Surgery +17